Clinical Trial Update: Clinical Value of ETCOc in the Diagnosis and Treatment of ABO-HDN

View source ↗

Summary

A clinical trial is ongoing to evaluate the clinical value of ETCOc in diagnosing and managing ABO hemolytic disease of the newborn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Abo Hemolytic Disease of the Newborn

Snippet

Sponsor: Women's Hospital School Of Medicine Zhejiang University | Conditions: ABO Hemolytic Disease of Newborn | Status: RECRUITING